Anticancer Activity of Sargassum fluitans Extracts in Different Cancer Cells
- PMID: 38385488
- DOI: 10.2174/0118715206282983240215050314
Anticancer Activity of Sargassum fluitans Extracts in Different Cancer Cells
Abstract
Background: The arrival of large quantities of Sargassum in the Mexican Caribbean Sea has generated major environmental, health and economic problems. Although Sargassum has been used in the generation of some commercial products, few studies have described its possible applications as a source of compounds with anticancer activity.
Objective: This study aimed to evaluate the antiproliferative effects of different Sargassum extracts on various cancer cell lines. Furthermore, LC/QTOF-MS was used to identify the compounds related to the antiproliferative effect.
Methods: First, determination of the seaweed was performed, and dichloromethane, chloroform and methanol extracts were obtained. The extracts were evaluated for their antiproliferative effects by MTT in breast (MDAMB- 231 and MCF-7), prostate (DU-145), lung (A549) and cervical (SiHa) cancer cell lines. Finally, LC/QTOFMS identified the compounds related to the antiproliferative effect.
Results: The authentication showed Sargassum fluitans as the predominant species. The extracts of dichloromethane and chloroform showed an antiproliferative effect. Interestingly, the fractionation of the chloroform extract showed two fractions (FC1 and FC2) with antiproliferative activity in MDA-MB-231, SiHa and A549 cancer cell lines. On the other hand, three fractions of dichloromethane extract (FD1, FD4 and FD5) also showed antiproliferative effects in the MDA-MB-231, MCF-7, SiHa and DU-145 cancer cell lines. Furthermore, LC/QTOF-MS revealed the presence of eight major compounds in FC2. Three compounds with evidence of anticancer activity were identified (D-linalool-3-glucoside, (3R,4S,6E,10Z)-3,4,7,11-tetramethyl-6,10-tridecadienal and alpha-tocotrienol).
Conclusion: These findings showed that Sargassum fluitans extracts are a possible source of therapeutic agents against cancer and could act as scaffolds for new drug discovery.
Keywords: Antiproliferation; LC/QTOF-MS; Sargassum fluitans; antiproliferative effect.; cancer; caribbean sea.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
UHPLC-MS/MS Studies and Antiproliferative Effects in Breast Cancer Cells of Mexican Sargassum.Anticancer Agents Med Chem. 2023;23(1):76-86. doi: 10.2174/1871520622666220412125740. Anticancer Agents Med Chem. 2023. PMID: 35418289
-
Differential growth inhibition of cancer cell lines and antioxidant activity of extracts of red, brown, and green marine algae.In Vitro Cell Dev Biol Anim. 2013 May;49(5):324-34. doi: 10.1007/s11626-013-9603-7. Epub 2013 May 4. In Vitro Cell Dev Biol Anim. 2013. PMID: 23645467
-
Chemical Characterization, In-silico Evaluation, and Molecular Docking Analysis of Antiproliferative Compounds Isolated from the Bark of Anthocephalus cadamba Miq.Anticancer Agents Med Chem. 2022;22(20):3416-3437. doi: 10.2174/1871520622666220204123348. Anticancer Agents Med Chem. 2022. PMID: 35125087
-
Chemical Profiling of Chlorophytum comosum (Thunb.) Jaques by GC-MS/LC-ESIMS and its Antiproliferative Effects on Human Carcinoma Cell Lines.Anticancer Agents Med Chem. 2021;21(13):1697-1707. doi: 10.2174/1871520620666201123085300. Anticancer Agents Med Chem. 2021. PMID: 33231161
-
New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.Bioorg Chem. 2021 Oct;115:105208. doi: 10.1016/j.bioorg.2021.105208. Epub 2021 Jul 26. Bioorg Chem. 2021. PMID: 34365057
Cited by
-
GC-MS analysis, anti-inflammatory and anti-proliferative properties of the aerial parts of three Mesembryanthemum spp.Toxicol Rep. 2024 Nov 28;13:101829. doi: 10.1016/j.toxrep.2024.101829. eCollection 2024 Dec. Toxicol Rep. 2024. PMID: 39735355 Free PMC article.
References
-
- Jonathan M.K.; Kelly C.; Frances E.D.; Weijia F.; Brian L.G.; Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: A systematic analysis for the global burden of disease study 2019. JAMA Oncol 2022,8(3),420-444 - DOI
-
- Roleira F.M.F.; Varela C.L.; Costa S.C.; Tavares-da-Silva E.J.; Phenolic derivatives from medicinal herbs and plant extracts: anticancer effects and synthetic approaches to modulate biological activity. Stu Nat Prod Chem 2018,57,115-156 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous